Senseonics, Inc.: Clinical Trials

12 trials sponsored by Senseonics, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 unknown, 2 recruiting, 1 active not recruiting. 12 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable12Completed 6, Unknown 3, Recruiting 2, Active not recruiting 1

Follow Senseonics, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ROME GS System Study
Continuous Glucose Monitoring System - Diabetes, Diabetes Melletus, Type 1
Not applicableRecruitingSenseonics, Inc.602026-02-122026-04-21
Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature
Continuous Glucose Monitoring System - Diabetes Mellitus, Diabetes Mellitus, Type 1
Not applicableRecruitingSenseonics, Inc.802025-12-292026-04-21
Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features
Continuous Glucose Monitoring System - Diabetes Mellitus, Diabetes Mellitus, Type 1
Not applicableUnknownSenseonics, Inc.3502021-10-202023-04-26
Eversense® Non-adjunctive Use Post Approval Study
Blood glucose meter, Eversense CGM System - Diabetes
Not applicableActive not recruitingSenseonics, Inc.9252021-04-132025-08-13
Post Approval Study of the Eversense® Continuous Glucose Monitoring
Eversense® CGM System - Diabetes Mellitus, Diabetes Mellitus, Type 1
Not applicableCompletedSenseonics, Inc.2732019-03-192025-06-12
PROMISE Study: An Evaluation of an Implantable Continuous Glucose Sensor up to 180 Days
Continuous Glucose Monitoring System - Diabetes Mellitus, Diabetes Mellitus, Type 1
Not applicableCompletedSenseonics, Inc.2082018-12-272024-08-20
Evaluation of the Eversense Continuous Glucose Monitoring System in Type I Diabetic Youth
Eversense Continuous Glucose Monitoring - Self Care
Not applicableCompletedKinderkrankenhaus auf der Bult152018-10-082024-10-15
PRECISION Study: Multi-center Study of Performance of a Novel Implanted CGM System Using a Next Generation Transmitter and Algorithm
Continuous glucose monitoring system - Diabetes Mellitus, Diabetes Mellitus, Type 1
Not applicableCompletedSenseonics, Inc.362017-07-252024-02-12
Home Use Sensor Study
Eversense (Senseonics) Continuous Glucose Monitoring System - Diabetes Mellitus
Not applicableUnknownSenseonics, Inc.172016-10-012017-05-22
A Feasibility Trial to Evaluate the Senseonics Continuous Glucose Monitoring System in Canada
Continuous Glucose Monitoring System - Diabetes Mellitus
Not applicableUnknownSenseonics, Inc.362016-10-012017-05-22
Evaluation of the Accuracy of an Implanted Glucose Sensor
Continuous Glucose Monitoring System - Diabetes Mellitus
Not applicableCompletedSenseonics, Inc.902016-01-012018-06-06
PRECISE: A Prospective, Multi-Center Evaluation of the Accuracy of a Novel Continuous Implanted Glucose Sensor
Continuous Glucose Monitoring Device (Senseonics) - Diabetes Mellitus
Not applicableCompletedSenseonics, Inc.812014-05-012016-01-21

Conditions studied

Diabetes Mellitus (11)  ·  Diabetes Mellitus, Type 1 (8)  ·  Diabetes Mellitus, Type 2 (8)

Interventions

Continuous Glucose Monitoring (9)

Countries

United States (8)  ·  Canada (1)  ·  Germany (1)  ·  Netherlands (1)  ·  Sweden (1)

Top investigators

Mark Christiansen, MD (2)  ·  J.Hans de Vries, MD (1)  ·  Kathleen Davis (1)  ·  Mona Landin-Olsson, M.D., Ph.D (1)  ·  Satish Garg, MD (1)  ·  Thomas Danne, MD (1)

Results publications

PMID 27815290, PMID 39869118